-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Iron Deficiency, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI), Hemoglobinopathies, Diseases, Lymphoid Malignancies, Myeloid Malignancies, Metabolic Disorders
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Room 11 (San Diego Convention Center)
Co-chairs:
Angela C Weyand, MD, University of Michigan and Adam Cuker, MD, MS, University of Pennsylvania
Disclosures:
Weyand: Genentech: Honoraria; Bayer: Honoraria; Novo Nordisk: Honoraria, Research Funding; Biomarin: Honoraria; Octapharma: Honoraria; Pfizer: Research Funding; Takeda: Consultancy, Honoraria, Research Funding; Hemab: Consultancy; Sanofi: Consultancy, Honoraria, Research Funding. Cuker: Bioverativ, MingSight Pharmaceuticals, Pfizer, Sanofi, Stago, Synergy: Consultancy; Alexion, Bayer, Bioverativ, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda: Research Funding.

This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.

Melissa Creary

University of Michigan School of Public Health, Ann Arbor, MI

Michelle Sholzberg, MDCM, MSc

St. Michael's Hospital, University of Toronto, Toronto, ON, Canada